Debra Richardson to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Debra Richardson has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.435
-
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO. Gynecol Oncol. 2025 Aug; 199:96-102.
Score: 0.229
-
Olaparib in the treatment of ovarian cancer. Future Oncol. 2019 Oct; 15(30):3435-3449.
Score: 0.153
-
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors. Clin Ther. 2024 Mar; 46(3):228-238.
Score: 0.052